课题基金 / 基金详情

A Multi-omics approach to Environment and Depression in Parkinsons disease (MOOD-PD)

A Multi-omics approach to Environment and Depression in Parkinsons disease (MOOD-PD)
帕金森病环境与抑郁症的多组学方法 (MOOD-PD)
批准号:
10304018
负责人:
Beate R Ritz
金额:
$23.4万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
已结题
起止时间:
2021-09-24 至 2023-08-31
关键词:
AddressAffectAgingAnxietyAnxiety DisordersBiologicalBiological ProcessCaliforniaCardiovascular systemCase-Control StudiesChronicCommunitiesComplexDNADNA MethylationDataDiagnosisDiseaseDisease ProgressionDoseElderlyEnvironmentEnvironmental ExposureEpigenetic ProcessExposure toFundingGenesGeneticGenetic Predisposition to DiseaseGenetic VariationGenomeGenomicsGeographic Information SystemsHealthHealthcareHomeHumanHuman CharacteristicsHuman ResourcesImmuneIndividualInflammatoryKnowledgeLeadLifeLife StyleLinkLocationLong-Term CareMapsMental DepressionMental HealthMental disordersMetabolicMethodsModernizationModificationMolecularMolecular ProfilingMood DisordersMultiomic DataNerve DegenerationNeurodegenerative DisordersNeurotransmittersOccupationalOnset of illnessOrganophosphatesParkinson DiseaseParticipantPathogenicityPathway AnalysisPathway interactionsPatientsPatternPeripheralPersonal SatisfactionPesticidesPhenotypePhysical activityPilot ProjectsPopulation ControlPopulation StudyPositioning AttributePredispositionPrevalenceProcessPublic HealthQuality of lifeQuantitative Trait LociRecording of previous eventsReportingResistanceResourcesRisk FactorsRoleSamplingSerumSocietiesStructure of molecular layer of cerebellar cortexSystemSystems AnalysisSystems BiologyTechnologyTimeToxic Environmental SubstancesToxicant exposureWorkWorkplaceagricultural pesticideanxiety symptomsbasebiological systemsbrain healthcholinergicclinical anxietycomorbiditycostdata resourcedepressive symptomsepigenomeepigenomicsfollow-upgenetic makeupgenome analysisgenome-widehigh riskimprovedinnovationinterestland usemachine learning methodmetabolomemetabolomicsminor depressive disordermodifiable riskmotor symptommultiple omicsneuropsychiatric disorderneuropsychiatryneurotoxicnon-motor symptomnovelpesticide exposurepopulation basedpyrethroidresidenceresponserural environmentscreeningsingle episode major depressive disordersupervised learningtool

项目摘要

项目成果

Beate R Ritz的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Project Abstract We propose to use metabolic and multi-omic markers to elucidate how chronic, long-term pesticide exposures affect the occurrence of depression and anxiety in elderly living in a rural environment and those who develop Parkinson’s disease (PD) and depression. Depression and anxiety disorders are the most common types of mental disorders in older adults. Depression prevalence is as high as 25% in long-term care settings and strongly contributes to health care use for comorbid illnesses1-5. Major depressive episodes and clinical anxiety occur at a much higher rate among PD patients even well before PD diagnosis1,2. Improving our understanding of modifiable risk factors and mechanisms involved in depression and anxiety amongst the elderly is an urgent public health matter. Over the past two decades, our team has generated a unique data resource that now provides us with the opportunity to investigate the contributions of common and important environmental exposures (pesticides) to depression and anxiety and to explore disease processes through multidimensional biologic networks. With prior funding, we have collected lifetime depression/anxiety diagnosis and treatment histories as well as current (and follow-up) status of depressive and anxiety symptoms in a large population- based case control study of PD among residents of the California Central Valley, including more than 500 PD patients we closely followed for over a decade. Among these individuals, as many as 38% of PD patients and 27% of elderly without PD reported a diagnosis of depression or anxiety disorder at any time during their life. For all study participants we have genome (Illumina Global Screening Array, 660K markers) data available, and for ~800 additionally we generated epigenome (Illumina Infinium 450K DNA platform; genome-wide DNA methylation) and untargeted metabolomic data (at two time points for 300 participants). We developed a longitudinal geographic information system (GIS) based assessment for pesticide exposures that links state-mandated information on type, date, and location of all agricultural pesticide applications in California recorded since 1974 to land use maps and study participants’ residences and work places. Additionally, we collected extensive information on occupational, home and gardening use of pesticides. Biologic processes, including biologic (metabolic, epigenetic) responses to chronic toxicant exposures or disease processes are dynamic but also dependent on genetic susceptibilities. Here, we propose to combine a powerful systems biology analytic approach to interrogate epigenetic and metabolomic data anchored in genetics to identify signatures for specific pesticide exposures (organophosphates, pyrethroids, neonicotinoids) and peripheral disease processes related to depression in PD. Our data uniquely position us to efficiently conduct a high-risk pilot study that investigates multidimensional networks using supervised machine learning methods to identify chronic response patterns in biologic systems across different molecular layers that can be linked to exposure and/or disease processes. Assembling our multi-omic data into multidimensional networks will address gaps in our current knowledge concerning molecular mechanisms contributing to depression and anxiety disorders in PD, a major neurodegenerative disorder of growing importance in aging societies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Air Pollution, Metabolome, and Alzheimer disease in Mexican Americans
A Multi-omics approach to Environment and Depression in Parkinsons disease (MOOD-PD)
Microbiome, Environment, and Parkinsons disease (MEP) PESTICIDE EXPOSURES AND THE GUT MICROBIOME IN PARKINSONS DISEASE
Microbiome, Environment, and Parkinsons disease (MEP) PESTICIDE EXPOSURES AND THE GUT MICROBIOME IN PARKINSONS DISEASE
海外基金